ArticleOncotarget2017
NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.
Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleOncotarget2017
Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.